Woo, Jong Shin <br/><br/>
Cardioprotective effects of exenatide in patients with ST-segment-elevation myocardial infarction undergoing primary percutaneous coronary intervention: results of exenatide myocardial protection in revascularization study.  [electronic resource] 

 -  Arteriosclerosis, thrombosis, and vascular biology  Sep 2013 
 - 2252-60 p.  digital 
<br/><br/> Publication Type: Journal Article; Randomized Controlled Trial; Research Support, Non-U.S. Gov't 
<br/><br/><label>ISSN: </label>1524-4636 
<br/><br/><label>Standard No.: </label>10.1161/ATVBAHA.113.301586  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Aged<br/>Biomarkers--blood<br/>Cardiotonic Agents--administration & dosage<br/>Chi-Square Distribution<br/>Creatine Kinase, MB Form--blood<br/>Drug Administration Schedule<br/>Echocardiography, Doppler<br/>Exenatide<br/>Female<br/>Humans<br/>Hypoglycemic Agents--administration & dosage<br/>Injections, Subcutaneous<br/>Magnetic Resonance Imaging<br/>Male<br/>Middle Aged<br/>Myocardial Contraction--drug effects<br/>Myocardial Infarction--blood<br/>Myocardium--enzymology<br/>Peptides--administration & dosage<br/>Percutaneous Coronary Intervention--adverse effects<br/>Predictive Value of Tests<br/>Proportional Hazards Models<br/>Prospective Studies<br/>Republic of Korea<br/>Stroke Volume--drug effects<br/>Time Factors<br/>Treatment Outcome<br/>Troponin I--blood<br/>Venoms--administration & dosage<br/>Ventricular Function, Left--drug effects